Glucose-1-phosphate uridylyltransferase from Erwinia amylovora: Activity, structure and substrate specificity

Stefano Benini, Mirco Toccafondi, Martin Rejzek, Francesco Musiani, Ben A. Wagstaff, Jochen Wuerges, Michele Cianci, Robert A. Field

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Erwinia amylovora, a Gram-negative plant pathogen, is the causal agent of Fire Blight, a contagious necrotic disease affecting plants belonging to the Rosaceae family, including apple and pear. E. amylovora is highly virulent and capable of rapid dissemination in orchards; effective control methods are still lacking. One of its most important pathogenicity factors is the exopolysaccharide amylovoran. Amylovoran is a branched polymer made by the repetition of units mainly composed of galactose, with some residues of glucose, glucuronic acid and pyruvate. E. amylovora glucose-1-phosphate uridylyltransferase (UDP-glucose pyrophosphorylase, EC 2.7.7.9) has a key role in amylovoran biosynthesis. This enzyme catalyses the production of UDP-glucose from glucose-1-phosphate and UTP, which the epimerase GalE converts into UDP-galactose, the main building block of amylovoran. We determined EaGalU kinetic parameters and substrate specificity with a range of sugar 1-phosphates. At time point 120 min the enzyme catalysed conversion of the sugar 1-phosphate into the corresponding UDP-sugar reached 74% for N-acetyl-α-D-glucosamine 1-phosphate, 28% for α-D-galactose 1-phosphate, 0% for α-D-galactosamine 1-phosphate, 100% for α-D-xylose 1-phosphate, 100% for α-D-glucosamine 1-phosphate, 70% for α-D-mannose 1-phosphate, and 0% for α-D-galacturonic acid 1-phosphate. To explain our results we obtained the crystal structure of EaGalU and augmented our study by docking the different sugar 1-phosphates into EaGalU active site, providing both reliable models for substrate binding and enzyme specificity, and a rationale that explains the different activity of EaGalU on the sugar 1-phosphates used. These data demonstrate EaGalU potential as a biocatalyst for biotechnological purposes, as an alternative to the enzyme from Escherichia coli, besides playing an important role in E. amylovora pathogenicity.

Original languageEnglish
Pages (from-to)1348-1357
Number of pages10
JournalBiochimica et Biophysica Acta - Proteins and Proteomics
Volume1865
Issue number11
DOIs
Publication statusPublished - Nov 2017

Keywords

  • Amylovoran
  • Biotechnology
  • Erwinia amylovora
  • GalU
  • Molecular docking
  • UDP-glucose pyrophosphorylase

Cite this